袖状胃切除术（以及减重手术总体）是一种致命的手术，会害死患者/缩短寿命。
原始表述
تكميم اه قاتل قاتل قاتل قاتل قاتل
按来源为原话. 译文由本项目提供；以阿拉伯语原文为准。
译文
袖状胃切除术（以及减重手术总体）是一种致命的手术，会害死患者/缩短寿命。
出处
- 来源状态
- 视频转录文本（本人原话）
- 归属
- Elawady (machine transcript)
- 视频
- Dr Diaa Al Awady د ضياء العوضي is live!لايف مش مهم خالص (打开来源)
- 发布日期
- 2026年2月11日
- 时间戳
- 0:58:06 (在原视频 YouTube 自动字幕轨中的位置；可确认该内容出现的位置，但不能确认说话人是谁)
- 归属的不确定性
- Archive transcript (YouTube CC or AI-generated); wording may contain transcription errors; no timestamps available.
- 所声称的机制
Removing most of the stomach destroys its function and leads to disease and death.
- 所声称的健康影响
Death; shortened life.
- 涉及人群
People with obesity considering surgery
- Elawady 设定的地域限制
none found
来源版本存在差异
- 来源状态
- 视频转录文本（本人原话）
- 归属
- Elawady (machine transcript)
- 视频
- الخوف حقيقه ام سراب. أضرار التكميم. بين الحقيقه والسراب (打开来源)
- 发布日期
- 2025年11月19日
- 时间戳
- 无（转录文本不含时间信息）
- 归属的不确定性
- Archive transcript (YouTube CC or AI-generated); wording may contain transcription errors; no timestamps available.
- 来源状态
- 视频转录文本（本人原话）
- 归属
- Elawady (machine transcript)
- 视频
- Dr Diaa Al Awady د ضياء العوضي is live! الموت المفاجيء (打开来源)
- 发布日期
- 2025年7月14日
- 时间戳
- 无（转录文本不含时间信息）
- 归属的不确定性
- Archive transcript (YouTube CC or AI-generated); wording may contain transcription errors; no timestamps available.
- 来源状态
- 档案网站引语（未注明出处）
- 归属
- Elawady (archive paraphrase; source video not given)
- 出处
- https://eltayebat.com/rule/bariatric-surgery/
- 归属的不确定性
- The archive attributes this wording to Dr. Diaa but gives no video reference.
科学评估
基本错误 – 该说法的主要部分没有证据支持，或被严重夸大。
证据确定性: 中 – 进一步研究仍可能影响该评估。
1. 说法是什么？
That sleeve/bariatric surgery is 'lethal' and kills patients.
2. 哪些内容可证实是正确的？
Deaths after bariatric surgery do occur: early postoperative mortality is about 0.04-0.3% in large registries/cohorts, and long-term deaths from accidents, suicide and alcohol are more frequent than in non-operated people with obesity (Adams 2007: 11.1 vs 6.4 per 10,000 person-years; SOS 2020: HR 1.85).
3. 哪些内容是错误或夸大的？
As a general statement it is contradicted: overall mortality is lower after surgery (SOS HR 0.77 over 24 years; Adams 40% lower; meta-analysis about 49% lower hazard and +6.1 years median life expectancy, with no difference between sleeve, bypass and banding).
4. 哪些内容仍不明确？
No randomized trial of survival exists; residual confounding could inflate the benefit. Sleeve-specific very-long-term (>20 years) survival data are limited.
5. 哪些研究支持该说法？
A-BAR-03 (excess non-disease deaths). A-BAR-16 and I-BAR-104 document increased suicide after surgery (Nordic suicide HR 1.68), and I-BAR-141 found no proven survival benefit in cohorts below median age, with more external-cause deaths. The Egyptian series I-BAR-105 reported 2 deaths in 892 sleeve operations (0.22%). None of these shows overall life-shortening.
6. 哪些研究与该说法相矛盾？
A-BAR-01, A-BAR-02, A-BAR-05, A-BAR-12, I-BAR-01; sleeve-specific: I-BAR-101 (Israel, sleeve vs usual care HR about 0.62) and I-BAR-102 (USA, sleeve HR 0.28 at 5 years); perioperative meta-analysis I-BAR-103 (sleeve 0.05%); guidelines I-BAR-107 (NICE NG246), I-DIAB-113 (ADA 2026), I-BAR-11 (ASMBS/IFSO 2022).
7. 对德国和欧洲而言情况如何？
Most key data are European (Sweden SOS/SOReg, Finland SLEEVEPASS, Switzerland SM-BOSS). European and international society guidelines consider bariatric surgery for severe obesity with lifelong follow-up.
8. 关于埃及的已知情况是什么？
No Egypt-specific outcome data were identified in this review. Elawady states in a transcript that sleeve gastrectomy is very widely performed in Egypt ('مصر كلها بتعملها'); the procedure-specific risks (reflux, deficiencies) apply wherever it is performed, and follow-up quality (supplements, endoscopy, mental-health screening) determines part of the risk.
9. 合理的实际结论是什么？
减重手术存在真实的风险，包括罕见的早期死亡以及自杀、意外事故和酒精问题风险的增加，但平均而言，它在重度肥胖者中与更长的生存期相关。
评估详情
- 证据确定性的依据
Survival data are observational (long-term RCT evidence on mortality is very uncertain, I-BAR-143), but large, consistent and long-term: SOS 24 years, an individual-level meta-analysis of 174,772 people including sleeve (I-BAR-01), and sleeve-specific matched cohorts from Israel and the USA (I-BAR-101, I-BAR-102). Perioperative mortality is directly measured and low (sleeve about 0.05%, I-BAR-103).
- 来源质量
Elawady's statement is a verbal assertion without cited data. Counter-evidence comes from prospective cohorts, registries and a meta-analysis.
- 地区可推广性
European data (Sweden) are direct.
- 个体例外情况
Individual deaths from complications do occur; risk is higher with complications, poor follow-up, alcohol misuse, or severe comorbidity.
- 说法的地域范围
- 普遍性（生物学/医学）
- 最近审核
- 2026年10月26日 初步
科学证据详解
已被科学证据否定 – 高质量证据显示情况恰恰相反，或该说法与已确立的生理学知识相矛盾。
研究问题: In adults with severe obesity, is sleeve gastrectomy (or bariatric surgery in general) associated with higher all-cause mortality or shorter life than comparable non-operated people?
研究问题详解 (PICO)
- 人群
- Adults with severe obesity (BMI >=35-40) eligible for bariatric surgery
- 干预或暴露
- Sleeve gastrectomy; other bariatric procedures
- 对照
- Matched non-operated people with obesity (usual care); general population for context
- 地域范围
- universal biology; health-system quality (surgical volume, follow-up) modifies risk
- 结局指标
- All-cause mortality
- Perioperative (30/90-day) mortality
- Cause-specific mortality (suicide, alcohol, external causes)
- Life expectancy
研究结果按作者报告呈现。我们的评估见下文。
哪些证据支持该说法？
Nordic study: survival after obesity surgery
Kauppila et al.. Gastroenterology 2019 · PMID 30940524 · DOI 10.1053/j.gastro.2019.03.048 队列研究已核查摘要新增Nordic registry study: operated patients still died about twice as often as the general population, and suicide deaths were higher than in obese non-operated people.
- 实际结果
- SMR 1.94 (1.83-2.05), 2.28 at >=15 y; suicide HR 1.68 (1.32-2.14); but all-cause HR 0.63 (0.60-0.66) vs obese non-operated.
- 方法学质量
- moderate (large registry cohort)
- 相关性
- indirect - supports only the existence of specific excess causes of death, not overall life-shortening; mostly older procedures
- 局限
- Registry confounding; few sleeve operations
Meta-analysis: does surgery prolong life at every age?
Meta-analysis: survival benefit of surgery was not demonstrated in cohorts below median age, and external-cause deaths were more frequent after surgery.
- 实际结果
- OR below median age 0.78 (0.57-1.06); above median age 0.23 (0.12-0.44).
- 方法学质量
- moderate (meta-analysis of observational studies)
- 相关性
- direct for young patients - limits the general benefit argument, does not show net harm
- 局限
- Study-level age split
Gastric bypass: fewer deaths overall, but more accident and suicide deaths
Utah cohort: deaths not caused by disease (accidents, suicide) were 58% higher after gastric bypass.
- 实际结果
- 11.1 vs 6.4 per 10,000 person-years; overall mortality 40% lower.
- 方法学质量
- moderate
- 相关性
- indirect (gastric bypass)
- 局限
- Older procedure
哪些证据不支持该说法？
Meta-analysis: weight-loss surgery and survival
Individual-level meta-analysis of matched cohorts: about 49% lower hazard of death and 6.1 years longer median life expectancy after surgery, with no difference between sleeve, bypass and banding.
- 实际结果
- Hazard reduction 49.2% (46.3-51.9); +6.1 years (5.2-6.9).
- 方法学质量
- moderate-high (large consistent observational evidence)
- 相关性
- direct, includes sleeve
- 局限
- Observational; residual confounding
US study: survival after sleeve and bypass
US matched cohort of 13,900 sleeve patients: lower 5-year mortality than matched usual-care patients.
- 实际结果
- SG HR 0.28 (0.13-0.57); unadjusted 1.02% vs 2.74%.
- 方法学质量
- moderate
- 相关性
- direct, sleeve-specific
- 局限
- 29-35% lost to follow-up
How often people die from weight-loss surgery itself
Meta-analysis of 3.6 million operations: perioperative death is rare.
- 实际结果
- Overall 0.08%; sleeve 0.05%.
- 方法学质量
- high for this outcome
- 相关性
- direct for "the operation kills"
- 局限
- Under-reporting possible
总体证据说明了什么？
基于上述研究的编辑评估——其本身并非研究结果。
哪种观点有更好的证据支持？
Bariatric surgery, including sleeve gastrectomy, is associated on average with lower mortality and longer life than continued severe obesity; early surgical death is rare (about 1 in 2,000 sleeves).
为什么有些研究权重更大
Large matched cohorts and an individual-participant meta-analysis with consistent direction outweigh mechanistic assertions; sleeve-specific cohorts (I-BAR-101, I-BAR-102) are given high weight for directness. The Cochrane NMA (I-BAR-143) shows RCT evidence on mortality is very uncertain because trials are small, so certainty rests on observational data.
因果关系是否已确立？ 很可能 Consistent large effects, dose-response with weight loss and plausible mechanisms; residual confounding (healthy-user effect) cannot be excluded without long-term RCTs.
仍存在的不确定性
Very long-term (>15 y) sleeve-specific survival; net effect in young adults; real excess of suicide and alcohol deaths.
合理的结论
The claim that sleeve gastrectomy is lethal or shortens life is false as a general statement; specific, rare fatal risks exist and require follow-up.
为什么研究结果看起来互相矛盾？
Studies with the general population as reference (SMR ~2, I-BAR-104; A-BAR-05 5.5 years shorter) and studies with obese non-operated controls (HR 0.5-0.8) answer different questions and do not conflict: operated people remain at higher risk than the general population but at lower risk than comparable people with obesity. Excess external-cause deaths (suicide, alcohol) coexist with large reductions in cardiovascular, cancer and diabetes deaths. Lack of benefit in young cohorts (I-BAR-141) reflects lower baseline risk and more external-cause deaths, not overall harm.
这是否取决于国家？
- 一般生物学效应
- Effect of surgery on survival is biological and procedure-related; universal.
- 饮食习惯
- Not applicable (surgical procedure, not a food).
- 食品原产地
- Not applicable (surgical procedure, not a food).
- 污染物
- Not applicable (surgical procedure, not a food).
- 本国生产条件
- Elawady states sleeve is very common in Egypt; perioperative risk depends on surgical volume and quality, which may vary between centres.
- 法律规则
- Not applicable.
- 实际监测数据
- No Egyptian national bariatric registry data were found; one Egyptian single-surgeon series (I-BAR-105) and one Egyptian RCT (I-BAR-136) were identified. The Egyptian series reported 0.22% 30-day mortality (2/892), within the range of international data but imprecise.
足以改变结论的地区差异没有可靠数据支持。
统计复核
- HR direction (reported as nonsurgical vs surgical) and CI symmetry; crude absolute risk for sleeve – Inverted HR surgery vs control: overall 0.50 (0.40-0.61), sleeve 0.62 (0.40-0.98); CIs log-symmetric; crude sleeve ARR 0.5 percentage points over ~3 y (reported 1.8 fewer deaths/1000 person-years). 已重新计算
- CI symmetry and unadjusted ARR/NNT – SG HR 0.28 CI log-symmetric (ratio 1.08); unadjusted 5-y ARR 1.7 percentage points (NNT ~58, observational). 已重新计算
- Translate pooled perioperative mortality into absolute frequencies; compare Egyptian series – Sleeve 0.05% = about 1 death per 2,000 operations; Egyptian series 0.22% (2/892). 已重新计算
- CI symmetry; SMR vs HR interpretation – All CIs log-symmetric; SMR (vs general population) and HR (vs obese controls) answer different questions. 已重新计算
总体证据的确定性（GRADE，简化版）
- 主要结局
- All-cause mortality after bariatric surgery (incl. sleeve) vs usual care
- 起始等级
- 低（观察性研究）
- 降级理由
- risk of bias: observational, residual confounding (not downgraded further because of consistency of matched designs)
- 升级理由
- large effect (HR ~0.5)
- consistency across countries and procedures
- 结果
- 中
由单名审查者参照 GRADE 方法进行的简化评估；并非正式的 GRADE 专家组评估。GRADE 评价的是针对某一结局的整体证据，而非单项研究。
已核查的临床指南和官方声明
- NICE: Overweight and obesity management (NG246), section 1.18 Bariatric surgery (2025 (last updated 8 Jan 2026)) · 原始文献
Offer referral for bariatric surgery assessment with BMI >=40, or 35-39.9 with a significant weight-related condition, if the person agrees to lifelong follow-up; lower thresholds by 2.5 for people of Middle Eastern, South Asian, Chinese and Black African/Caribbean background; follow-up >=2 years in the bariatric service and at least annual nutritional monitoring and supplementation afterwards. - NICE: Obesity: identification, assessment and management (CG189) (2014 (last updated 2023)) · 原始文献
Page states that CG189 has been updated and replaced by NICE guideline NG246; content therefore taken from NG246. - ASMBS/IFSO: 2022 ASMBS and IFSO Indications for Metabolic and Bariatric Surgery (I-BAR-11) (2022) · 原始文献
Metabolic and bariatric surgery is recommended for BMI >35 regardless of comorbidities and should be considered for BMI 30-34.9 with metabolic disease; long-term results consistently demonstrate safety and efficacy (abstract; erratum noted in PubMed). - ADA: Standards of Care in Diabetes-2026, Section 8 (I-DIAB-113) (2026) · 原始文献
Consider metabolic surgery in type 2 diabetes with BMI >=30 (>=27.5 Asian American) (A); long-term medical and behavioural support with routine micronutrient and metabolic monitoring (B); routine psychosocial screening after surgery (C); text cites lower relapse after RYGB than sleeve (5-y relapse 33.1% vs 41.6%). - AACE/TOS/ASMBS/OMA/ASA: Clinical Practice Guidelines for Perioperative Nutrition, Metabolic and Nonsurgical Support (I-BAR-09) (2019) · 原始文献
Executive summary: bariatric procedures remain a safe and effective intervention for higher-risk patients with obesity; a team approach to perioperative care is mandatory, with special attention to nutritional and metabolic issues (abstract).
检索策略
本次审查的文献检索记录（检索式采用原数据库语法）。
| 数据库 | 日期 | 检索式 | 检索目标 | 命中数 | 纳入数 |
|---|---|---|---|---|---|
| PubMed | 2026年10月26日 | (bariatric surgery[tiab] OR sleeve gastrectomy[tiab]) AND (increased mortality[ti] OR excess mortality[ti] OR "mortality" [ti]) AND (external causes OR suicide OR accidents OR younger OR late mortality) | 支持性证据 | 43 | |
| Europe PMC | 2026年10月26日 | TITLE:"bariatric" AND (TITLE:"cause-specific mortality" OR TITLE:"excess mortality" OR TITLE:"late mortality" OR TITLE:"external causes") | 支持性证据 | 3 | |
| Europe PMC | 2026年10月26日 | (TITLE:"bariatric" OR TITLE:"sleeve gastrectomy" OR TITLE:"metabolic surgery") AND (TITLE:"mortality" OR TITLE:"survival" OR TITLE:"life expectancy") AND (PUB_TYPE:"Meta-Analysis" OR TITLE:"meta-analysis") AND PUB_YEAR:[2019 TO 2026] | 反对性证据 | 14 | |
| Europe PMC | 2026年10月26日 | (TITLE:"sleeve gastrectomy") AND (TITLE:"mortality" OR TITLE:"survival") AND (TITLE:"usual care" OR TITLE:"nonsurgical" OR TITLE:"matched" OR TITLE:"cohort") | 反对性证据 | 4 | |
| PubMed | 2026年10月26日 | (sleeve gastrectomy[ti] OR bariatric[ti]) AND (all-cause mortality[ti] OR long-term mortality[ti]) AND (usual care OR nonsurgical OR matched controls) | 反对性证据 | 9 | |
| Europe PMC | 2026年10月26日 | AFF:"Egypt" AND (TITLE:"sleeve gastrectomy" OR TITLE:"bariatric") AND (TITLE:"mortality" OR TITLE:"complications" OR TITLE:"deficiency" OR TITLE:"anemia") | 双向 | 19 | |
| Europe PMC | 2026年10月26日 | JOURNAL:"Cochrane Database Syst Rev" AND (TITLE:"surgery for weight loss" OR TITLE:"bariatric" OR TITLE:"obesity surgery" OR TITLE:"surgery for obesity") | 指南 | 13 | |
| Web (guideline site) | 2026年10月26日 | https://www.nice.org.uk/guidance/cg189 ; https://www.nice.org.uk/guidance/ng246 ; .../chapter/Medicines-and-surgery | 指南 | ||
| Web (guideline site) | 2026年10月26日 | https://pmc.ncbi.nlm.nih.gov/articles/PMC12690172/ (ADA Standards of Care 2026, section 8) | 指南 |
待解决的问题
Sleeve-specific survival beyond 15 years; outcomes in Egyptian practice (no national registry found).
核查深度如何？
18 项相关研究：7 项核查了全文（其中 3 项进行了结构化偏倚风险评估），11 项基于摘要核查，0 项仅核查了文献信息。 尚未进行由两名独立审查者完成的正式评估，也尚未进行独立的人类专家审核。
最近一次科学审核: 2026年10月26日
评定结论的变更历史
- 2026年10月25日 · 第 1 阶段 · 初始评估: 基本错误 (中)
- 2026年10月26日 · 第 4 阶段（系统证据审查） · 在扩展证据后重新审查；评定结论不变: 基本错误 (中)
Verdict and certainty unchanged. New sleeve-specific mortality cohorts (I-BAR-101, I-BAR-102) and a perioperative meta-analysis (I-BAR-103) strengthen the contradicting evidence; new limiting evidence (I-BAR-104, I-BAR-141, I-BAR-143) confirms real excess external-cause deaths, no proven benefit in young cohorts and very uncertain RCT data, which justifies keeping MOSTLY_FALSE rather than FALSE and certainty at moderate.
新来源: I-BAR-101 I-BAR-102 I-BAR-103 I-BAR-107 I-DIAB-113 I-BAR-104 I-BAR-105 I-BAR-141 I-BAR-143
通俗解释
Elawady 称袖状胃切除术是"致命的"。大型研究并不支持把这当作一般性陈述。做过减重手术的人平均比没有做手术的类似人群活得更久：在瑞典约长 3 年，在一项大型 Meta分析中约长 6 年。术后头几周内的死亡很少见（远低于 1%）。然而，术后自杀、意外事故和酒精导致的死亡确实有所增加，因此心理健康随访很重要。
与该说法相关的研究
支持该说法的研究 (1)
-
Gastric bypass: fewer deaths overall, but more accident and suicide deaths
Adams TD et al.. N Engl J Med 2007 · PMID 17715409 · DOI 10.1056/NEJMoa066603队列研究被 Tayebat 档案网站引用已核查摘要★ 关键研究Total deaths were 40% lower after surgery, while deaths from accidents and suicide were higher (11.1 vs 6.4 per 10,000 person-years).
Sleeve gastrectomy (and bariatric surgery in general) is a lethal operation that kills patients / shortens life.
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Long-term mortality
- 研究是如何开展的？
Matched retrospective cohort
- 研究了多少人、动物或样本？
15,850 people
- 实际发现了什么？
Total deaths down, external-cause deaths up
- 观察到的效应有多大？
37.6 vs 57.1 total; 11.1 vs 6.4 non-disease per 10,000 PY
- 研究结果对日常生活意味着什么？
Net survival benefit with a specific mental health and accident risk
- 该研究有哪些局限？
Observational
- 它对 Elawady 的具体说法说明了什么？
Supports self-harm concern, contradicts 'lethal'
- 研究结果是否适用于德国和欧洲？
Comparable to Nordic findings
- 从该研究中明确不能得出什么结论？
Causation of suicide excess
该组中没有被标记为关键研究的研究。
与该说法相矛盾或限制该说法的研究 (11)
-
Short-term safety of weight-loss surgery in the US
Flum DR et al.. N Engl J Med 2009 · PMID 19641201 · DOI 10.1056/NEJMoa0901836队列研究被 Tayebat 档案网站引用全文，含结构化偏倚风险评估About 3 in 1000 patients died within 30 days; 4.3% had a serious complication.
Sleeve gastrectomy (and bariatric surgery in general) is a lethal operation that kills patients / shortens life.
该研究是否支持这一具体说法？ 否 · 方法学质量: 高 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Measure early risks
- 研究是如何开展的？
Prospective multicentre cohort
- 研究了多少人、动物或样本？
4776 adults
- 实际发现了什么？
Low early mortality (0.3%)
- 观察到的效应有多大？
30-day death 0.3%
- 研究结果对日常生活意味着什么？
Serious early complications are uncommon but real
- 该研究有哪些局限？
Only 30 days; sleeve operations excluded; experienced centres; no non-surgical comparison
- 它对 Elawady 的具体说法说明了什么？
Does not support 'lethal'; documents a small real risk
- 研究结果是否适用于德国和欧洲？
Similar to European data
- 从该研究中明确不能得出什么结论？
Long-term effects
-
Swedish study: fewer deaths after weight-loss surgery
Sjöström L et al.. N Engl J Med 2007 · PMID 17715408 · DOI 10.1056/NEJMoa066254队列研究被 Tayebat 档案网站引用已核查摘要Over about 11 years, people who had surgery had roughly 24-29% lower risk of dying than matched controls.
Sleeve gastrectomy (and bariatric surgery in general) is a lethal operation that kills patients / shortens life.
该研究是否支持这一具体说法？ 否 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Test mortality effect
- 研究是如何开展的？
Prospective matched study
- 研究了多少人、动物或样本？
4047 adults
- 实际发现了什么？
Fewer deaths after surgery
- 观察到的效应有多大？
Adjusted HR 0.71
- 研究结果对日常生活意味着什么？
Surgery was linked to living longer
- 该研究有哪些局限？
Not randomized; older techniques
- 它对 Elawady 的具体说法说明了什么？
Argues against 'surgery kills'
- 研究结果是否适用于德国和欧洲？
Directly European
- 从该研究中明确不能得出什么结论？
Exact causal size
-
Swedish 24-year study: surgery added about 3 years of life
Carlsson LMS et al.. N Engl J Med 2020 · PMID 33053284 · DOI 10.1056/NEJMoa2002449队列研究被 Tayebat 档案网站引用已核查全文★ 关键研究Operated patients lived about 3 years longer than non-operated patients with obesity, but still about 5.5 years less than the general population (non-operated: about 8.5 years less).
Sleeve gastrectomy (and bariatric surgery in general) is a lethal operation that kills patients / shortens life.
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Life expectancy
- 研究是如何开展的？
Prospective controlled cohort with population reference
- 研究了多少人、动物或样本？
5182 people
- 实际发现了什么？
Surgery gained 3 years; gap to population 5.5 vs 8.5 years
- 观察到的效应有多大？
HR death 0.77; +3.0 years
- 研究结果对日常生活意味着什么？
Surgery reduced but did not remove the life-expectancy loss linked to severe obesity
- 该研究有哪些局限？
Not randomized; old operations
- 它对 Elawady 的具体说法说明了什么？
Number correct, implication 'surgery shortens life' wrong
- 研究结果是否适用于德国和欧洲？
Directly European
- 从该研究中明确不能得出什么结论？
That surgery causes the remaining 5.5-year gap
-
Swedish registry: early complications after bypass
Stenberg E et al.. Ann Surg 2014 · PMID 24374541 · DOI 10.1097/SLA.0000000000000431队列研究被 Tayebat 档案网站引用已核查摘要Serious complications 3.4%; deaths within 90 days 4 in 10,000.
Sleeve gastrectomy (and bariatric surgery in general) is a lethal operation that kills patients / shortens life.
该研究是否支持这一具体说法？ 否 · 方法学质量: 高 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Early risks
- 研究是如何开展的？
Registry
- 研究了多少人、动物或样本？
26,173
- 实际发现了什么？
Low mortality
- 观察到的效应有多大？
0.04%
- 研究结果对日常生活意味着什么？
Death from the operation is rare
- 该研究有哪些局限？
Short-term
- 它对 Elawady 的具体说法说明了什么？
Contradicts 'lethal'
- 研究结果是否适用于德国和欧洲？
European
- 从该研究中明确不能得出什么结论？
Long-term harms
-
Meta-analysis: weight-loss surgery and survival
Syn NL et al.. Lancet 2021 · PMID 33965067 · DOI 10.1016/S0140-6736(21)00591-2Meta分析独立交叉核查已核查摘要★ 关键研究Across 174,772 people, surgery was linked to about half the risk of death and about 6 more years of median life expectancy; sleeve showed similar effects to bypass.
Sleeve gastrectomy (and bariatric surgery in general) is a lethal operation that kills patients / shortens life.
该研究是否支持这一具体说法？ 否 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Survival
- 研究是如何开展的？
Meta-analysis of matched cohorts
- 研究了多少人、动物或样本？
174,772
- 实际发现了什么？
Lower mortality
- 观察到的效应有多大？
HR ~0.51; +6.1 years
- 研究结果对日常生活意味着什么？
Surgery is linked to longer, not shorter, life in severe obesity
- 该研究有哪些局限？
Observational studies
- 它对 Elawady 的具体说法说明了什么？
Contradicts 'lethal'
- 研究结果是否适用于德国和欧洲？
Includes Europe
- 从该研究中明确不能得出什么结论？
Exact causal size
-
Body weight and death risk worldwide
Global BMI Mortality Collaboration. Lancet 2016 · PMID 27423262 · DOI 10.1016/S0140-6736(16)30175-1Meta分析独立交叉核查全文，含结构化偏倚风险评估Severe obesity (BMI 40+) was linked to nearly 3 times the death risk of normal weight.
Sleeve gastrectomy (and bariatric surgery in general) is a lethal operation that kills patients / shortens life.
该研究是否支持这一具体说法？ 否 · 方法学质量: 高 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
BMI-mortality
- 研究是如何开展的？
IPD meta-analysis
- 研究了多少人、动物或样本？
~4 million
- 实际发现了什么？
Higher BMI, higher mortality
- 观察到的效应有多大？
HR 2.76 grade 3
- 研究结果对日常生活意味着什么？
Severe obesity itself shortens life
- 该研究有哪些局限？
Observational
- 它对 Elawady 的具体说法说明了什么？
Context for SOS gap
- 研究结果是否适用于德国和欧洲？
Includes Europe
- 从该研究中明确不能得出什么结论？
Effect of weight loss
-
Israeli study: deaths after sleeve, bypass and banding vs usual care
Reges et al.. JAMA 2018 · PMID 29340677 · DOI 10.1001/jama.2017.20513队列研究独立交叉核查已核查全文★ 关键研究People who had surgery, including sleeve, died less often over about 4 years than similar people with obesity who did not (sleeve 0.8% vs 1.3%).
Sleeve-specific lower mortality vs usual care.
该研究是否支持这一具体说法？ 否 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Compare death rates after three operations with usual care
- 研究是如何开展的？
Matched cohort from health-fund records
- 研究了多少人、动物或样本？
8,385 operated, 25,155 controls
- 实际发现了什么？
Lower mortality with every operation, including sleeve
- 观察到的效应有多大？
Sleeve: HR about 0.62 (surgery vs control)
- 研究结果对日常生活意味着什么？
On average, sleeve did not shorten life in the first years
- 该研究有哪些局限？
Observational; short follow-up for sleeve
- 它对 Elawady 的具体说法说明了什么？
Contradicts "sleeve is lethal"
- 研究结果是否适用于德国和欧洲？
Health-system data from Israel; plausible for Europe
- 从该研究中明确不能得出什么结论？
Cannot prove causation or show very long-term effects
-
US study: survival after sleeve and bypass
Courcoulas et al.. Ann Surg 2023 · PMID 34387200 · DOI 10.1097/SLA.0000000000005155队列研究独立交叉核查已核查全文★ 关键研究Over 5 years, people who had a sleeve died about 70% less often than similar people who did not have surgery (1.0% vs 2.7%).
SG associated with lower 5-y mortality.
该研究是否支持这一具体说法？ 否 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Compare deaths after SG/RYGB with matched non-operated patients
- 研究是如何开展的？
Matched cohort, health records
- 研究了多少人、动物或样本？
13,900 SG; 17,258 RYGB; 87,965 controls
- 实际发现了什么？
Lower death rates after both operations
- 观察到的效应有多大？
SG HR 0.28 (0.13-0.57)
- 研究结果对日常生活意味着什么？
Sleeve was not associated with earlier death
- 该研究有哪些局限？
About one third lost to follow-up; observational
- 它对 Elawady 的具体说法说明了什么？
Contradicts "sleeve kills"
- 研究结果是否适用于德国和欧洲？
Plausible for Europe and Egypt
- 从该研究中明确不能得出什么结论？
Cannot exclude unmeasured confounding
-
How often people die from weight-loss surgery itself
Robertson et al.. Br J Surg 2021 · PMID 34297806 · DOI 10.1093/bjs/znab245Meta分析独立交叉核查已核查摘要★ 关键研究About 1 in 2,000 sleeve operations ends in death around the time of surgery.
Early surgical mortality is rare (~0.05% for sleeve), so "lethal operation" is not supported; deaths do occur.
该研究是否支持这一具体说法？ 否 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Measure early death risk
- 研究是如何开展的？
Meta-analysis
- 研究了多少人、动物或样本？
>3.6 million patients
- 实际发现了什么？
Overall 0.08%, sleeve 0.05%
- 观察到的效应有多大？
0.05% for sleeve
- 研究结果对日常生活意味着什么？
Death from the operation is rare but not zero
- 该研究有哪些局限？
Reporting differences between sources
- 它对 Elawady 的具体说法说明了什么？
Contradicts "lethal" as a general statement
- 研究结果是否适用于德国和欧洲？
Mostly Western data
- 从该研究中明确不能得出什么结论？
Long-term mortality
-
UK NICE guideline on obesity surgery
NICE. National Institute for Health and Care Excellence 2025指南 / 立场声明独立交叉核查已核查摘要★ 关键研究NICE recommends considering surgery for people with severe obesity and requires lifelong yearly checks of nutrition.
Guideline recommends surgery for defined adults.
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 高 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Guide care
- 研究是如何开展的？
Guideline
- 研究了多少人、动物或样本？
not applicable
- 实际发现了什么？
Surgery is an option; lifelong follow-up
- 观察到的效应有多大？
not applicable
- 研究结果对日常生活意味着什么？
Surgery needs lifelong aftercare
- 该研究有哪些局限？
National context
- 它对 Elawady 的具体说法说明了什么？
Contradicts "lethal", supports "lifelong supplements"
- 研究结果是否适用于德国和欧洲？
UK
- 从该研究中明确不能得出什么结论？
Individual decisions
-
US diabetes standards 2026: weight loss and type 2 diabetes
American Diabetes Association Professional Practice Committee for Diabetes. Diabetes Care 2026 · PMID 41358882 · DOI 10.2337/dc26-S008指南 / 立场声明独立交叉核查已核查全文★ 关键研究Losing more than 10% of body weight can lead to remission of type 2 diabetes and reduce the need for insulin.
Recommends metabolic surgery as an option.
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 高 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Guide weight management.
- 研究是如何开展的？
Guideline.
- 研究了多少人、动物或样本？
Not applicable.
- 实际发现了什么？
Weight loss >10% may induce remission.
- 观察到的效应有多大？
Not applicable.
- 研究结果对日常生活意味着什么？
Weight loss is a powerful treatment for type 2 diabetes.
- 该研究有哪些局限？
Guideline.
- 它对 Elawady 的具体说法说明了什么？
Supports the T2D kernel of C-DIAB-03.
- 研究结果是否适用于德国和欧洲？
European guidance agrees.
- 从该研究中明确不能得出什么结论？
Not applicable to T1D.
该组中没有被标记为关键研究的研究。
结果不一或不明确的研究 (6)
-
Pregnancy after weight-loss surgery
Johansson K et al.. N Engl J Med 2015 · PMID 25714159 · DOI 10.1056/NEJMoa1405789队列研究被 Tayebat 档案网站引用已核查摘要Less gestational diabetes and fewer large babies, but more small babies.
Sleeve gastrectomy (and bariatric surgery in general) is a lethal operation that kills patients / shortens life.
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Pregnancy
- 研究是如何开展的？
Matched cohort
- 研究了多少人、动物或样本？
670 exposed
- 实际发现了什么？
Mixed
- 观察到的效应有多大？
SGA OR 2.20; GDM OR 0.25
- 研究结果对日常生活意味着什么？
Pregnancy after surgery needs monitoring
- 该研究有哪些局限？
Few deaths
- 它对 Elawady 的具体说法说明了什么？
Mixed
- 研究结果是否适用于德国和欧洲？
European
- 从该研究中明确不能得出什么结论？
Causality
-
Swedish cohorts: more self-harm after surgery
Neovius M et al.. Lancet Diabetes Endocrinol 2018 · PMID 29329975 · DOI 10.1016/S2213-8587(17)30437-0队列研究被 Tayebat 档案网站引用全文，含结构化偏倚风险评估Self-harm and suicide were more frequent after surgery, but absolute risks were low.
Sleeve gastrectomy (and bariatric surgery in general) is a lethal operation that kills patients / shortens life.
该研究是否支持这一具体说法？ 是 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Self-harm
- 研究是如何开展的？
Matched cohorts
- 研究了多少人、动物或样本？
>40,000
- 实际发现了什么？
Higher risk
- 观察到的效应有多大？
aHR 1.78-3.16
- 研究结果对日常生活意味着什么？
Mental-health follow-up is needed
- 该研究有哪些局限？
Observational; few suicides; self-selection; no sleeve gastrectomy
- 它对 Elawady 的具体说法说明了什么？
Supports risk; authors oppose general discouragement
- 研究结果是否适用于德国和欧洲？
European
- 从该研究中明确不能得出什么结论？
Mechanism; that surgery shortens life overall; risk after sleeve
-
Nordic study: survival after obesity surgery
Kauppila et al.. Gastroenterology 2019 · PMID 30940524 · DOI 10.1053/j.gastro.2019.03.048队列研究独立交叉核查已核查摘要★ 关键研究Operated people died less often than non-operated people with obesity, but more often than the general population; suicide deaths were more frequent.
Overall mortality lower (HR 0.63) but suicide HR 1.68.
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Compare survival with two reference groups
- 研究是如何开展的？
Registry cohort
- 研究了多少人、动物或样本？
505,258 (49,977 operated)
- 实际发现了什么？
HR 0.63 vs obese; SMR 1.94 vs general population
- 观察到的效应有多大？
All-cause HR 0.63; suicide HR 1.68
- 研究结果对日常生活意味着什么？
Surgery reduces but does not remove the excess risk of obesity
- 该研究有哪些局限？
Older procedures; registry data
- 它对 Elawady 的具体说法说明了什么？
Contradicts "lethal", supports "still shorter life than general population"
- 研究结果是否适用于德国和欧洲？
Direct European data
- 从该研究中明确不能得出什么结论？
Sleeve-specific long-term effects
-
Egyptian surgeon series: early safety of sleeve
El Masry et al.. World J Surg 2023 · PMID 37548678 · DOI 10.1007/s00268-023-07123-0病例系列 / 病例报告独立交叉核查已核查摘要2 of 892 patients died within 30 days (0.22%).
Egyptian series: 2 deaths in 892 sleeve operations (0.22%) - rare but not zero.
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 低 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Report early complications
- 研究是如何开展的？
Single-surgeon series
- 研究了多少人、动物或样本？
892
- 实际发现了什么？
Mortality 0.22%
- 观察到的效应有多大？
2/892
- 研究结果对日常生活意味着什么？
Early death is uncommon
- 该研究有哪些局限？
One surgeon, no comparison
- 它对 Elawady 的具体说法说明了什么？
Shows deaths occur but are rare
- 研究结果是否适用于德国和欧洲？
Egyptian practice
- 从该研究中明确不能得出什么结论？
Long-term outcomes
-
Meta-analysis: does surgery prolong life at every age?
Pontiroli et al.. Obes Surg 2020 · PMID 32152843 · DOI 10.1007/s11695-020-04530-3Meta分析独立交叉核查已核查摘要Surgery was linked to fewer deaths in older patients, but in younger patients no clear survival benefit was shown.
No proven mortality benefit below median age (OR 0.78, NS); external-cause deaths increased.
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Age and mortality benefit
- 研究是如何开展的？
Meta-analysis
- 研究了多少人、动物或样本？
not stated
- 实际发现了什么？
Benefit above median age only
- 观察到的效应有多大？
OR 0.78 (young) vs 0.23 (older)
- 研究结果对日常生活意味着什么？
Younger patients may not gain survival
- 该研究有哪些局限？
Study-level age split
- 它对 Elawady 的具体说法说明了什么？
Partly supports a nuance, not "lethal"
- 研究结果是否适用于德国和欧洲？
Applicable
- 从该研究中明确不能得出什么结论？
Net harm in young people
-
Cochrane review: surgery for obesity with type 2 diabetes
Kiesswetter et al.. Cochrane Database Syst Rev 2026 · PMID 42610488 · DOI 10.1002/14651858.CD015622.pub2Meta分析独立交叉核查已核查摘要★ 关键研究Trials show more weight loss and better blood sugar after surgery, but long-term data on complete diabetes remission, serious harms and deaths are very uncertain.
RCT evidence on long-term mortality very uncertain (7 RCTs, n=520).
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 高 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Benefits/harms of MBS in T2D
- 研究是如何开展的？
Cochrane NMA
- 研究了多少人、动物或样本？
15,282
- 实际发现了什么？
Weight and HbA1c better; remission/mortality very uncertain
- 观察到的效应有多大？
RYGB weight MD -17%
- 研究结果对日常生活意味着什么？
Surgery helps, but long-term certainty is limited
- 该研究有哪些局限？
Few RCT participants
- 它对 Elawady 的具体说法说明了什么？
Partly supports erosion claim; does not show harm
- 研究结果是否适用于德国和欧洲？
Applicable
- 从该研究中明确不能得出什么结论？
Precise long-term effects
该组中没有被标记为关键研究的研究。
地区背景
德国 / 欧盟
Most key data are European (Sweden SOS/SOReg, Finland SLEEVEPASS, Switzerland SM-BOSS). European and international society guidelines consider bariatric surgery for severe obesity with lifelong follow-up.
埃及
No Egypt-specific outcome data were identified in this review. Elawady states in a transcript that sleeve gastrectomy is very widely performed in Egypt ('مصر كلها بتعملها'); the procedure-specific risks (reflux, deficiencies) apply wherever it is performed, and follow-up quality (supplements, endoscopy, mental-health screening) determines part of the risk.
在我的国家适用什么？
一般科学评估
基本错误 作为一般性陈述，这是错误的：平均而言，减重手术（包括袖状胃切除术）在重度肥胖者中与较低的死亡率和较长的寿命相关，手术本身导致的死亡很少见（每 2,000 例袖状胃切除术约 1 例）；确实存在一些特定的罕见致命风险（并发症、自杀、酒精）。
该说法涉及生物学或医学关系。上述科学评估不论在哪个国家都适用；各国食品数据不会改变这一评估。
参考文献
- Long-term mortality after gastric bypass surgery.. Adams TD et al.. N Engl J Med 2007 · PMID 17715409 · DOI 10.1056/NEJMoa066603
- Perioperative safety in the longitudinal assessment of bariatric surgery.. Flum DR et al.. N Engl J Med 2009 · PMID 19641201 · DOI 10.1056/NEJMoa0901836
- Effects of bariatric surgery on mortality in Swedish obese subjects.. Sjöström L et al.. N Engl J Med 2007 · PMID 17715408 · DOI 10.1056/NEJMoa066254
- Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study.. Carlsson LMS et al.. N Engl J Med 2020 · PMID 33053284 · DOI 10.1056/NEJMoa2002449
- Early complications after laparoscopic gastric bypass surgery: results from the Scandinavian Obesity Surgery Registry.. Stenberg E et al.. Ann Surg 2014 · PMID 24374541 · DOI 10.1097/SLA.0000000000000431
- Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants.. Syn NL et al.. Lancet 2021 · PMID 33965067 · DOI 10.1016/S0140-6736(21)00591-2
- Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents.. Global BMI Mortality Collaboration. Lancet 2016 · PMID 27423262 · DOI 10.1016/S0140-6736(16)30175-1
- Association of Bariatric Surgery Using Laparoscopic Banding, Roux-en-Y Gastric Bypass, or Laparoscopic Sleeve Gastrectomy vs Usual Care Obesity Management With All-Cause Mortality.. Reges et al.. JAMA 2018 · PMID 29340677 · DOI 10.1001/jama.2017.20513
- Reduction in Long-term Mortality After Sleeve Gastrectomy and Gastric Bypass Compared to Nonsurgical Patients With Severe Obesity.. Courcoulas et al.. Ann Surg 2023 · PMID 34387200 · DOI 10.1097/SLA.0000000000005155
- Perioperative mortality in bariatric surgery: meta-analysis.. Robertson et al.. Br J Surg 2021 · PMID 34297806 · DOI 10.1093/bjs/znab245
- Overweight and obesity management (NICE guideline NG246; replaces CG189). NICE. National Institute for Health and Care Excellence 2025
- 8. Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes-2026.. American Diabetes Association Professional Practice Committee for Diabetes. Diabetes Care 2026 · PMID 41358882 · DOI 10.2337/dc26-S008
- Outcomes of pregnancy after bariatric surgery.. Johansson K et al.. N Engl J Med 2015 · PMID 25714159 · DOI 10.1056/NEJMoa1405789
- Risk of suicide and non-fatal self-harm after bariatric surgery: results from two matched cohort studies.. Neovius M et al.. Lancet Diabetes Endocrinol 2018 · PMID 29329975 · DOI 10.1016/S2213-8587(17)30437-0
- Effects of Obesity Surgery on Overall and Disease-Specific Mortality in a 5-Country Population-Based Study.. Kauppila et al.. Gastroenterology 2019 · PMID 30940524 · DOI 10.1053/j.gastro.2019.03.048
- Perioperative Morbidity and Mortality of Laparoscopic Sleeve Gastrectomy (LSG) in a Single-Surgeon Experience on 892 Patients Over 11 Years.. El Masry et al.. World J Surg 2023 · PMID 37548678 · DOI 10.1007/s00268-023-07123-0
- Compared with Controls, Bariatric Surgery Prevents Long-Term Mortality in Persons with Obesity Only Above Median Age of Cohorts: a Systematic Review and Meta-Analysis.. Pontiroli et al.. Obes Surg 2020 · PMID 32152843 · DOI 10.1007/s11695-020-04530-3
- Metabolic and bariatric surgery in adults with obesity and diabetes mellitus: a network meta-analysis.. Kiesswetter et al.. Cochrane Database Syst Rev 2026 · PMID 42610488 · DOI 10.1002/14651858.CD015622.pub2